Predictors of Human Papillomavirus Vaccine Follow-Through Among Privately Insured US Patients

Objectives. To assess predictors of timely human papillomavirus (HPV) vaccine follow-through among privately insured individuals initiating the 3-dose series. Methods. Using MarketScan Commercial claims data, we identified 1 332 217 privately insured US individuals aged 9 to 26 years who initiated t...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Am J Public Health
Autores principales: Spencer, Jennifer C., Brewer, Noel T., Trogdon, Justin G., Wheeler, Stephanie B., Dusetzina, Stacie B.
Formato: Artigo
Lenguaje:Inglês
Publicado: American Public Health Association 2018
Materias:
AJPH Research
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5993378/
https://ncbi.nlm.nih.gov/pubmed/29771616
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2105/AJPH.2018.304408
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares